Suppression assays with human T regulatory cells: A technical guide
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The suppression of inappropriate immune responses by Treg cells is one of the major ways that the body maintains immune tolerance and homeostasis. Since defects in the suppressive capacity of Treg cells underlie many different immune‐mediated diseases, there is great interest in developing ways to track the number and function of Treg cells as biomarkers of tolerance and in devising ways to enhance their function therapeutically. However, the methods of studying human Treg cells are fraught with technical challenges that can often lead to misinterpretation. The most common way to determine the suppressive capacity of human Treg cells is to measure their ability to suppress the proliferation of responding CD4 + T cells. Here, we discuss the technical considerations that must be taken into account when performing suppression of T‐cell proliferation assays with human Treg cells. We also consider how T cells may falsely appear suppressive because of dying cells in the system, improper resting of T‐cell lines prior to the assay, or insufficient proliferation of the responding T cells. We propose that, in the future, classification of a population of cells as “regulatory” should rely on more than a simple test for blockade of CD4 + T‐cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently the only way to confidently quantify human Tregs is to use a panel of different markers and then carry out parallel functional [381], gene expression [382], and/or epigenetic analyses [383, 384].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [381]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cutting Edge: Human Regulatory T Cells Require IL-35 To Mediate Suppression and Infectious Tolerance
Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J., & Vignali, D. A. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100315 · Cited by 205
RetractedPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,325
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Research works printed but not linked: 2
- & 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu Eur. J. Immunol. 2012. 42: 27-34
- & 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu Eur. J. Immunol. 2012. 42: 27-34 45
Cited by
Items 101–147 of 147
Breitman, M., Bonfield, T. L., Caplan, A. I., Lazarus, H. M., Haghiac, M., Lasalvia, S., Reese‐Koc, J., & Singer, N. G. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11356 · Cited by 7
“Suppression indices were calculated as previously published (16).”
MethodKos, K., Baalen, M. V., Meijer, D. A., & de Visser, K. E. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.035 · Cited by 6
Endothelial Cells Activated by Extracellular Histones Promote Foxp3+ Suppressive Treg Cells In Vitro
Arnaud, M., Demonchy, J., Arrii, E., Luperto, M., Lion, J., Fodil, S., Pons, S., Mooney, N., & Zafrani, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094527 · Cited by 6
“We determined whether Tregs inhibited proliferation of autologous T lymphocytes in response to anti-CD3/CD28 coated beads as previously described [19,20] and illustrated in”
ODN 2216 Uptake Induced TLR9 Signaling Mediates Phenotypic Changes in CD4+ T Cells
Sharma, R. K., Sharma, J., Kumar, R., Badal, D., Pattekar, A., Sehgal, S., Gupta, A., Jain, P., & Sachdeva, N. K. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.13214 · Cited by 5
Basak, P., Badal, D., Dayal, D., Bhadada, S. K., Kumar, R., & Sachdeva, N. K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115045 · Cited by 5
Technical Considerations in Ex Vivo Human Regulatory T Cell Migration and Suppression Assays
Irekeola, A. A., Rahman, E. N. S. E. A., Lazim, N. M., Mohamud, R., Yean, C. Y., & Shueb, R. H. (2020) · Cells · doi:10.3390/cells9020487 · Cited by 6
“The use of 3H-thymidine incorporation depends on the premise that Tregs are anergic following in vitro stimulation with anti-CD3 monoclonal antibodies but responsive upon addition of IL-2, and they are therefore not expected to incorporate 3H-thymidine in the absence of IL-2 [76,77].”
BackgroundKanjana, K., Paisooksantivatana, K., Matangkasombut, P., Chevaisrakul, P., & Lumjiaktase, P. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1659813 · Cited by 5
“Treg functional study provides a way to explore the immune status, which involves a co-culture suppression assay to evaluate Treg suppression status of a subject.([10,11]) However, the amount of Treg in PB of healthy humans constitutes a small fraction (2–5% of CD4+ T cells) required for co-culture experiments, especi…”
BackgroundYaz, İ., Halaçlı, S. O., İpşir, C., Ulum, B., Aytekin, E. S., Bildik, H. N., Ocak, M., Avcı, H., Okur, F. V., Gülşen, H. H., et al. (2025) · Journal of Clinical Immunology · doi:10.1007/s10875-025-01934-7 · Cited by 4
“Further functional studies such as suppression testing could be performed [10].”
The Role of Tregs in the Tumor Microenvironment
Sato, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13051173 · Cited by 8
“An in vitro suppression assay was conducted to assess suppressive function [24,25].”
A novel method for assaying human regulatory T cell direct suppression of B cell effector function
Weingartner, E., Courneya, J.-P., Keegan, A. D., & Golding, A. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.11.004 · Cited by 4
“Variables which have been shown to influence suppression include the ratio of Treg to Tconv in co-culture, the nature of stimulation (ranging from soluble to plate-bound to bead-conjugated antiCD3 or anti-CD28 as well as inclusion of various inert antigen presenting cells providing co-stimulation), and the addition of…”
BackgroundInfluentialHaque, N. S., Tuteja, A., & Haque, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218944 · Cited by 4
Shalev-Malul, G., Soler, D. C., Ting, A. E., Lehman, N., Barnboym, E., McCormick, T. S., Anthony, D. D., Lazarus, H. M., Caplan, A. I., Breitman, M., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0299 · Cited by 4
de Wolf, A. C. M. T., Herberts, C. A., & Hoefnagel, M. H. N. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00091 · Cited by 4
“Most of these assays aim to measure inhibition of effector T cell proliferation or cytokine production, although cytotoxicity inhibition may also be used as read-out (193, 194).”
BackgroundBrezar, V., Ruffin, N., Lévy, Y., & Seddiki, N. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.06.003 · Cited by 3
Isolation and Characterization of Both Human and Mouse Tfh/Tfr Cells
Tulyeu, J., Søndergaard, J. N., Sakaguchi, S., & Wing, J. B. (2021) · Current Protocols · doi:10.1002/cpz1.283 · Cited by 3
Immune Monitoring during Cancer Immunotherapy
Shehata, H. M., Dogra, P., & Sanjabi, S. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch105 · Cited by 3
Omori‐Miyake, M., Kawakami, R., Kuwahara, M., Okabe, M., Muto, J., Imamura, T., & Yamashita, M. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.01.036 · Cited by 2
Moya-Guzmán, M. J., González-Mienert, E., Pinto, C., & Pino‐Lagos, K. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag019 · Cited by 2
“14”
A method for screening functional anti-Treg antibodies using a Treg-like cell line
Pfeffer, K., Ho, T. H., Ruiz, Y. W., & Lake, D. F. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae257 · Cited by 1
Assessing Human Treg Suppression at Single-Cell Resolution Using Mass Cytometry
Søndergaard, J. N., Tulyeu, J., Priest, D., Sakaguchi, S., & Wing, J. B. (2025) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5424 · Cited by 1
Moya-Guzmán, M. J., Solminihac, J. D., Carrasco-Loncharic, T., Kaehne, T., & Pino‐Lagos, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1777669 · Cited by 3
“Suppression was calculated as previously described (12).”
The future of TCR-Treg therapies is renewables
Peh, C. R., Nguyen‐Dumont, T., Ting, Y. T., & Ooi, J. D. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104139 · Cited by 2
Regulatory T Cell (Treg) Characterization
Cepika, A., & Bacchetta, R. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch25 · Cited by 2
Natural CD4+CD25+FOXP3+ regulatory T cells in graft-versus-host disease
Edinger, M., & Hoffmann, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416004-0.00012-4 · Cited by 1
In vitro generation of human FOXP3+ regulatory T cells
Abdulrasool, G. A. E. S. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Modulation of immune tolerance: the role of tolerogenic dendritic cells and TNFα
Boks, M. A. (2012) · UvA-DARE (University of Amsterdam)
Choi, K.-Y. G. (2016) · Mspace (University of Manitoba)
Intrinsic Mechanisms Regulating T Cell Tolerance in Autoimmune Diabetes
Zhang, Q. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Thymus-Derived CD4+CD25+ FOXP3+ Regulatory T Cells in GVHD
Edinger, M., & Hoffmann, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00013-x
Bhattacharjee, A., Burr, A. B. P., Overacre-Delgoffe, A. E., Tometich, J. T., Yang, D., Huckestein, B. R., Linehan, J. L., Spencer, S. P., Hall, J. A., Harrison, O. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.130831
“Suppression was calculated as previously described 587 (McMurchy and Levings, 2012).”
MethodHan, S. (2017) · TSpace (University of Toronto)
Cheng, Y.-H., & Gadziola, M. A. (2021) · UTSC s Journal of Natural Sciences · doi:10.33137/jns.v2i1.34611
“Finally, a Treg cell suppression assay is essential in identifying whether Treg cells are functioning normally by labelling CD4+CD25+ T cells (McMurchy & Levings, 2012).”
BackgroundMethodInfluentialAssessment of Functional Immune Responses in Lymphocytes
Abraham, R. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00094-0
Effect of neonatal BCG vaccination on the evolution of Hashimoto’s ThyroiditisPreprint
Agrawal, K., Basak, P., Badal, D., Dutta, P. R., Walia, R., & Sachdeva, N. K. (2024) · medRxiv · doi:10.1101/2024.02.28.24303481
Single cell suppression profiling of human regulatory T cellsPreprint
Søndergaard, J. N., Tulyeu, J., Priest, D., Sakaguchi, S., & Wing, J. B. (2024) · Research Square · doi:10.21203/rs.3.rs-4327429/v1
Albany, C. J., Mastronicola, D., Popov, M., Stroukov, W., Wierzbicki, A. S., Martínez-Nuñez, R. T., Lombardi, G., & Scottà, C. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4835840
Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
Bacchetta, R., & Alexander, J. L. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00108-3
Bhat, S., Basak, P., Verma, S., Siddiqui, K., Dutta, P. R., Das, L., Singh, H., Bhadada, S. K., & Sachdeva, N. K. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127604
Enhancing specific thymic Treg activation and function with 4-1BB monomeric streptavidin-based CARs
Gallego-Valle, J., Pérez-Fernández, V. A., Pita, A., Magallares, J. R., López-Esteban, R., Gil-Manso, S., Carbonell, D., Pérez–Caballero, R., Pardo, C., Gil‐Jaurena, J., et al. (2025) · Translational research · doi:10.1016/j.trsl.2025.09.004
Komoike, Y., Kamiya, D., Sasaki-Ban, H., Matsuda, A., Matsumoto, H., & Ikeya, M. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101081
“MSCs or their EV-mediated suppression of effector T cell proliferation in PBMCs was evaluated following a previously described suppression assay [10].”
Preclinical development of a T cell based gene therapy to treat IPEX syndrom
Delville, M. (2019) · theses.fr (ABES) · doi:10.70675/a98fdc5dz0036z4620z848ez66c60ea7bd96
Nijhuis, L., Scholman, R. C., Lalmohamed, A., Vastert, S. J., & van Loosdregt, J. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03846-2
“…the relative proliferation of the CD4 + or CD8 + T cell fraction within cultured PBMCs in the presence of Tregs compared with PBMCs cultured alone, using the following formula: 100 − ((percentage proliferation in the presence of Tregs / percentage proliferation in the absence of Tregs) × 100; [37].”
Shudde, C. E., Tabrez, S. S. M., Jin, Y., Rosario-Crespo, A., Reid, K., Kaneshige, A., Bai, L., Yang, Y., Wang, S., Kim, C. H., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201817
Li, X., Zheng, J., Zhou, D., Limpert, R., Taylor, B., Tian, L., Yu, X., Drobyski, W. R., & Chen, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1599346
Metadata
- Authors
- McMurchy, A. N., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Levings, Megan K.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2011-12-12
- Volume
- 42
- Issue
- 1
- Pages
- 27-34
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1963511922
- Cited by
- 147
- References
- 64
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 14 · 2023: 6 · 2022: 12 · 2021: 15 · 2020: 12 · 2019: 12 · 2018: 7 · 2017: 11 · 2016: 11 · 2015: 7 · 2014: 10 · 2013: 6 · 2012: 4
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Michael Smith Health Research BC
- Roche Organ Transplant Research Foundation
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- regulatory T cells, Treg suppressive function, CD4+ T cells, immune tolerance, immune-mediated diseases
- MeSH terms
- Flow Cytometry, Humans, Immune Tolerance, T-Lymphocytes, Regulatory, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.